182 related articles for article (PubMed ID: 2532043)
1. [Photogeneration of singlet molecular oxygen by the components of hematoporphyrin IX derivative].
Egorov SIu; Tauber AIu; Krasnovskiĭ AA; Nizhnik AN; Nokel' AIu; Mironov AF
Biull Eksp Biol Med; 1989 Oct; 108(10):440-2. PubMed ID: 2532043
[TBL] [Abstract][Full Text] [Related]
2. [Photosensitized formation of singlet oxygen in water solutions of covalent porphyrin-antibody conjugates].
Egorov SIu; Krasnovskiĭ AA; Pankovskiĭ DB; Ponomarev GV; Savitskiĭ AP
Biull Eksp Biol Med; 1990 Apr; 109(4):349-51. PubMed ID: 2386825
[TBL] [Abstract][Full Text] [Related]
3. Syntheses and photosensitizing activity of porphyrins joined with ester linkages.
Pandey RK; Dougherty TJ
Cancer Res; 1989 Apr; 49(8):2042-7. PubMed ID: 2522815
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of hematoporphyrin IX potential for photodynamic therapy by entrapment in silica nanospheres.
Silva PR; Vono LL; Espósito BP; Baptista MS; Rossi LM
Phys Chem Chem Phys; 2011 Sep; 13(33):14946-52. PubMed ID: 21769362
[TBL] [Abstract][Full Text] [Related]
5. [Study of kinetic parameters of singlet molecular oxygen in aqueous porphyrin solutions. Effect of detergents and the quencher sodium azide].
Butorina DN; Krasnovskiĭ AA; Priezzhev AV
Biofizika; 2003; 48(2):201-9. PubMed ID: 12723342
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fluorescence and photodynamic activities of whole hematoporphyrin derivative and its enriched active components.
Nelson JS; Wright WH; Berns MW
J Natl Cancer Inst; 1985 Dec; 75(6):1135-40. PubMed ID: 2933546
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy: status and potential.
Dougherty TJ
Oncology (Williston Park); 1989 Jul; 3(7):67-73; discussion 74, 77-8. PubMed ID: 2534944
[TBL] [Abstract][Full Text] [Related]
8. Influence of medium polarity on the photosensitizing properties of hematoporphyrin and hematoporphyrin derivative (Photofrin II).
Shopova M; Gantchev T
J Photochem Photobiol B; 1988 Nov; 2(3):365-71. PubMed ID: 2853216
[TBL] [Abstract][Full Text] [Related]
9. Sonodynamic therapy of cancer using novel sonosensitizers.
Kuroki M; Hachimine K; Abe H; Shibaguchi H; Kuroki M; Maekawa S; Yanagisawa J; Kinugasa T; Tanaka T; Yamashita Y
Anticancer Res; 2007; 27(6A):3673-7. PubMed ID: 17970027
[TBL] [Abstract][Full Text] [Related]
10. Cellular accumulation and biological activity of hematoporphyrin derivative(L) in comparison with photofrin II.
Khanum F; Jain V
Indian J Exp Biol; 1997 Apr; 35(4):348-55. PubMed ID: 9315233
[TBL] [Abstract][Full Text] [Related]
11. Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas.
Gibson SL; Murant RS; Hilf R
Cancer Res; 1988 Jun; 48(12):3360-6. PubMed ID: 2836053
[TBL] [Abstract][Full Text] [Related]
12. Singlet oxygen quantum yields of potential porphyrin-based photosensitisers for photodynamic therapy.
Mathai S; Smith TA; Ghiggino KP
Photochem Photobiol Sci; 2007 Sep; 6(9):995-1002. PubMed ID: 17721599
[TBL] [Abstract][Full Text] [Related]
13. The photodynamic effects of photofrin II, hematoporphyrin derivative, hematoporphyrin, and tetrasodium-mesotetra(4-sulfonatophenyl)porphine in vitro: clonogenic cell survival and drug uptake studies.
West CM; Moore JV
Photochem Photobiol; 1989 Feb; 49(2):169-74. PubMed ID: 2523543
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
15. Quantum yields and kinetics of the photobleaching of hematoporphyrin, Photofrin II, tetra(4-sulfonatophenyl)-porphine and uroporphyrin.
Spikes JD
Photochem Photobiol; 1992 Jun; 55(6):797-808. PubMed ID: 1409888
[TBL] [Abstract][Full Text] [Related]
16. Hematoporphyrin ethers--III. Cellular uptake and photosensitizing properties.
Moan J; Rimington C; Western A
Int J Biochem; 1988; 20(12):1401-4. PubMed ID: 2977342
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of malignant tumors.
McCaughan JS
Prog Clin Biol Res; 1988; 278():163-9. PubMed ID: 2974994
[No Abstract] [Full Text] [Related]
18. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
El-Far M; Pimstone N
Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
[TBL] [Abstract][Full Text] [Related]
19. [Phototherapy of tumors using photosensitizing agents].
Gamalev NF; Mikhalkin IA
Eksp Onkol; 1988; 10(1):9-16. PubMed ID: 2967173
[TBL] [Abstract][Full Text] [Related]
20. Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives.
You Y; Gibson SL; Hilf R; Davies SR; Oseroff AR; Roy I; Ohulchanskyy TY; Bergey EJ; Detty MR
J Med Chem; 2003 Aug; 46(17):3734-47. PubMed ID: 12904078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
